Hydrogel crosslinking mechanisms influence the release and functional delivery of lipid nanoparticles

Vaccines have long been our most powerful shield against infectious disease, teaching the immune system to recognize and defeat invaders before they cause harm. For decades, this training relied on injecting a piece of the germ itself, or a harmless version of it, to spark a response. In recent years, a newer, more flexible technology has emerged: messenger RNA vaccines. Instead of delivering a piece of the virus, these vaccines deliver a set of genetic instructions that tell our own cells to build a specific protein, training the immune system just as effectively. To get these fragile instructions inside our cells, scientists wrap them in tiny, microscopic bubbles made of fat, known as lipid nanoparticles. These bubbles protect the genetic cargo and help it slip through the cell's outer wall. However, a challenge remains: once injected, these instructions are often used up quickly, and the training signal fades away. Nature, by contrast, often presents threats over days or weeks, giving the immune system time to build a stronger, longer-lasting defense. Scientists have long wondered if they could create a delivery system that releases these instructions slowly, keeping the training signal active for longer, much like a slow-release capsule for medicine.

A team of researchers set out to solve this problem by testing whether a soft, jelly-like material called a hydrogel could serve as a holding pen for these fat bubbles. Hydrogels are networks of molecules that trap water, forming a structure that is mostly liquid but holds its shape, similar to a very soft gelatin dessert. The researchers wanted to see if they could mix the vaccine bubbles into this jelly and let them escape slowly over time. But they knew that not all jellies are the same. Some are held together by strong chemical bonds, others by electrical attractions, and some by the way proteins naturally tangle together. The team suspected that the specific way the jelly was built would change how the bubbles moved, how long they stayed safe, and whether they could still do their job once they finally emerged. To find the answer, they created four different types of hydrogels, each with a unique way of holding its shape, and loaded them with the vaccine bubbles.

The scientists first checked if the bubbles could survive inside these jellies. They used two types of bubbles: one filled with a glowing dye to track their movement, and another filled with the actual genetic instructions for making a fluorescent protein. They placed these bubbles into the four hydrogel systems and watched what happened over several days. They found that all four types of jelly eventually let the bubbles out, but the speed and the amount that got out varied wildly depending on the jelly's recipe. The chemical bonds that held the first type of jelly together allowed for the most control; by changing how much material was used, the researchers could make the bubbles come out fast or slow. However, even in this best-case scenario, some of the glowing dye leaked out of the bubbles before they were fully recovered, suggesting the bubbles were slightly stressed. In another type of jelly, held together by electrical charges, the bubbles came out, but they became more scattered and less uniform in size. A third type, made of a temperature-sensitive material that turns into a gel when warmed, released the bubbles very quickly, but the jelly itself dissolved so fast that it was hard to separate the bubbles from the remaining material. The fourth type, made from natural proteins found in the body, was the most complex. While it was difficult to measure exactly how many bubbles came out because the jelly didn't fully dissolve, the ones that did emerge were in excellent shape.

The researchers then looked at the bubbles themselves to see if the journey through the jelly had changed them. They used a powerful microscope that could see individual particles frozen in a thin layer of ice. They discovered that the bubbles looked different depending on the temperature they were kept at. Bubbles kept in a cool environment looked somewhat loose and irregular. But bubbles that had been kept at body temperature, whether they were sitting in a test tube or had just come out of a hydrogel, looked more compact and dense. This change happened even without the jelly, simply because of the warmth, suggesting that the bubbles naturally tighten up when they get warm. Crucially, the researchers found that the hydrogels did not break the bubbles apart or destroy their structure; the particles remained intact and ready to work.

The most important test was whether the bubbles could still deliver their message after escaping the jelly. The team placed the hydrogels above a layer of human cells in a dish and waited for the bubbles to drift down and enter the cells. They found that the cells successfully took up the bubbles from every type of hydrogel. When they checked if the cells had received the instructions and started making the protein, the results were clear. The bubbles that had traveled through the protein-based jelly were just as effective as the ones that had never been in a jelly at all, producing high levels of the target protein. The bubbles from the chemically bonded jelly also worked well, though their performance dipped slightly as the jelly became denser. The bubbles from the electrically charged jelly and the temperature-sensitive jelly showed reduced performance, with the latter struggling to get the message across effectively, even though the bubbles themselves had survived the trip.

These findings reveal that the material used to hold the vaccine is just as important as the vaccine itself. While all the hydrogels tested were able to release the bubbles, the specific way the jelly was built determined how well the bubbles kept their shape and how well they could deliver their cargo. The protein-based jelly, which mimics the natural environment of the body, proved to be the most promising, preserving the full power of the vaccine instructions. The study shows that it is possible to create a slow-release system for these advanced vaccines, but it requires careful selection of the delivery material. By choosing the right kind of jelly, scientists can potentially extend the time the immune system sees the vaccine, leading to stronger and longer-lasting protection against disease. This work provides a clear path forward for designing better vaccine delivery systems that keep the body's training signal active for as long as it needs to be.